United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read General business news Matrimony.com sees billing surge but profit tumbles—What’s next for the matchmaking giant? Matrimony.com’s Q4 FY25 results show 5% billing growth but 30% PAT drop. Find out what it means for India’s leading matchmaking platform’s future. byPallavi MadhirajuMay 16, 2025